Suppr超能文献

儿童造血干细胞移植后的妊娠和妊娠结局:EBMT 儿科疾病工作组的横断面调查。

Pregnancy and pregnancy outcomes after hematopoietic stem cell transplantation in childhood: a cross-sectional survey of the EBMT Pediatric Diseases Working Party.

机构信息

Division of Pediatric Oncology/Hematology, University Children's Hospital Basel, UKBB, University of Basel, Basel, Switzerland.

Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

出版信息

Hum Reprod. 2021 Oct 18;36(11):2871-2882. doi: 10.1093/humrep/deab199.

Abstract

STUDY QUESTION

What are the characteristics of patients with conceptions transplanted in childhood and adolescence?

SUMMARY ANSWER

Insemination and conception after hematopoietic stem cell transplantation (HCT) in childhood or adolescence was possible, even after myeloablative conditioning regimes, although some patients required reproductive medicine support.

WHAT IS KNOWN ALREADY

Preparative regimens of HCT are highly gonadotoxic, which leads to gonadal failure and pubertal development disorders. There are few population-based studies assessing the risk of future infertility in children after HCT.

STUDY DESIGN, SIZE, DURATION: We conducted a retrospective study to investigate natural or assisted conceptions and their outcomes in patients <18 years old before their first transplantation who received HCT between 1995 and 2016 and were in the European Society for Blood and Marrow Transplantation (EBMT) registry. Adoptions were excluded from the analysis.

PARTICIPANTS/MATERIALS, SETTING, METHODS: Detailed information concerning pregnancy occurrences and outcomes were obtained by a separate questionnaire. Quantitative variables were presented as medians with their interquartile range (IQR) or range, and categorical variables were presented as frequencies and percentages.

MAIN RESULTS AND THE ROLE OF CHANCE

In total, 62 988 pediatric patients received a first HCT in EBMT centers between 1995 and 2016. Pregnancy was reported in 406 patients in the database. The median age at transplantation was 15.7 (range: 0.7-18) years, and the median age at declared conception was 25.0 (range: 16.3-38.8) years. Details concerning the first pregnancy and pregnancy outcome were obtained from 99 patients (24%) from the returned questionnaires. The median age at delivery or pregnancy interruption of the females was 23.0 (IQR: 20.8-27) years, with a median time after transplant of 10.7 (IQR: 6.6-15.4) years. Compared with the mean age of healthy women at their first child's birth (29 years old), the transplanted women delivered 5 years earlier (mean: 24.3 years). In terms of conception modality, 13/25 (52%) females conditioned with total body irradiation (TBI) and 50/52 (96%) of those conditioned without TBI conceived naturally. All seven male patients who had been conditioned with TBI achieved fatherhood but required assisted fertilization or used their cryopreserved sperm. In the females, 63/70 (90%) of all conceptions resulted in a live birth, 49/63 (84.5%) were at term and 43/46 (93%) had normal birthweight. Cesarean delivery was performed in 9/61 (15%) especially in women who had received a myeloablative regimen.

LIMITATIONS, REASONS FOR CAUTION: In the EBMT pediatric dataset, the age at last follow-up or death was <17 years for 75% of the patients, therefore a longer follow-up for all patients would be necessary to calculate the cumulative incidence of conception for patients transplanted during childhood and allow all patients to realize their reproductive willingness/potential.

WIDER IMPLICATIONS OF THE FINDINGS

Reproductive health surveillance and fertility preservation counseling are important in younger transplanted patients. Our results showed that there is a window of opportunity to conceive naturally or with reproductive medicine support.

STUDY FUNDING/COMPETING INTEREST(S): Funding was provided by the 'Stiftung für krebskranke Kinder Regio Basiliensis', Basel, Switzerland. All authors have no conflicts of interest to declare.

TRIAL REGISTRATION NUMBER

N/A.

摘要

研究问题

儿童和青少年时期接受移植妊娠的患者有哪些特点?

总结答案

在儿童或青少年时期接受造血干细胞移植(HCT)后,即使在接受清髓性预处理方案后,也有可能进行授精和妊娠,但一些患者需要生殖医学支持。

已知情况

HCT 的预处理方案具有高度的性腺毒性,会导致性腺功能衰竭和青春期发育障碍。很少有基于人群的研究评估 HCT 后儿童未来不孕的风险。

研究设计、大小和持续时间:我们进行了一项回顾性研究,调查了 1995 年至 2016 年间在第一次移植前年龄小于 18 岁且在欧洲血液和骨髓移植协会(EBMT)注册中心接受 HCT 的患者的自然或辅助妊娠及其结局。排除了收养情况。

参与者/材料、设置、方法:通过单独的问卷获得了有关妊娠发生和结局的详细信息。定量变量以中位数及其四分位距(IQR)或范围表示,分类变量以频率和百分比表示。

主要结果和机会的作用

在总共 62988 名接受 EBMT 中心 1995 年至 2016 年第一次 HCT 的儿科患者中,有 406 名患者在数据库中报告了妊娠。移植时的中位年龄为 15.7(范围:0.7-18)岁,首次妊娠时的中位年龄为 25.0(范围:16.3-38.8)岁。从 99 名(24%)返回问卷的患者中获得了有关首次妊娠和妊娠结局的详细信息。女性的中位分娩或妊娠中断年龄为 23.0(IQR:20.8-27)岁,移植后中位时间为 10.7(IQR:6.6-15.4)年。与健康女性首次分娩的平均年龄(29 岁)相比,接受移植的女性生育年龄提前了 5 岁(平均年龄:24.3 岁)。就受孕方式而言,13/25(52%)名接受全身照射(TBI)预处理的女性自然受孕,50/52(96%)名未接受 TBI 预处理的女性自然受孕。所有 7 名接受 TBI 预处理的男性患者都成为了父亲,但需要辅助受精或使用冷冻精子。在女性中,70 名所有受孕中的 63 名(90%)导致活产,49 名(84.5%)足月,43 名(93%)出生体重正常。特别是在接受清髓性方案治疗的女性中,有 9/61(15%)进行了剖宫产。

局限性、谨慎的原因:在 EBMT 儿科数据集中,75%的患者最后一次随访或死亡时的年龄<17 岁,因此需要对所有患者进行更长时间的随访,以计算儿童时期接受移植的患者妊娠的累积发生率,并允许所有患者实现他们的生殖意愿/潜力。

更广泛的影响

生殖健康监测和生育力保存咨询对年轻的移植患者很重要。我们的结果表明,存在自然受孕或借助生殖医学支持受孕的机会窗口。

研究资金/利益冲突:该研究由瑞士巴塞尔贝塞尔斯基金会(Stiftung für krebskranke Kinder Regio Basiliensis)提供资金。所有作者均无利益冲突。

临床试验注册号

无。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验